ΔF508-CFTR channels: Kinetics, activationby forskolin, and potentiation by xanthines

American Journal of Physiology - Cell Physiology

Volumn 270, Issue 5 39-5, 1996, Pages

  Haws, C M ^b   Nepomuceno, I B ^b   Krouse, M E ^b   Wakelee, H ^b   Law, T ^b   Xia, Y ^b   Nguyen, H ^b   Wine, J J ^a  

^a STANFORD UNIVERSITY   (United States)

^b NONE

Author keywords

3 isobutyl 1 methylxanthine; 8 cyclopentyl 1,3 dipropylxanthine; Adenosine 3 ,5 cyclic monophosphate; Chloride channels; Cystic fibrosis transmembrane conductance regulator; Efflux; Patch clamp

Indexed keywords

TRIXIS; ANIMALIA;

8 CYCLOPENTYLTHEOPHYLLINE; CHLORIDE CHANNEL; CYCLIC AMP; FORSKOLIN; IODINE 125; ISOBUTYLMETHYLXANTHINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; XANTHINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CHLORIDE CONDUCTANCE; CONTROLLED STUDY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CELL LINE; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROPHYSIOLOGY; FORSKOLIN; GLYCOSYLATION; IODINE; MICE; MUTATION; TIME FACTORS; XANTHINES;

EID: 0029899053     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.270.5.c1544     Document Type: Article

References (43)

1. Barthelson, R., and J. Widdicombe. Cyclic adenosine monophosphate-dependent kinase in cystic fibrosis tracheal epithelium. J. Clin. Invest. 80: 1799-1802, 1987.
2. Beavo, J. A. Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv. Second Messenger Phosphoprotein Res. 22: 1-38, 1988.
3. Beavo, J. A., and D. H. Reifsnyder. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11: 150-155, 1990.
4. Cheng, S. H., S. L. Fang, J. Zabner, J. Marshall, S. Piraino, S. C. Schiavi, D. M. Jefferson, M. J. Welsh, and A. E. Smith. Functional activation of the cystic fibrosis trafficking mutant ΔF508 CFTR by overexpression. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12) 268: L615-L624, 1995.
5. Cheng, S. H., R. J. Gregory, J. Marshall, S. Paul, D. W. Souza, G. A. White, C. R. O'Riordan, and A. E. Smith. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834, 1990.
6. --secreting epithelial cells. Proc. Natl. Acad. Sci. USA 87: 4956-4960, 1990.
7. Croce, M. A., G. L. Kramer, and D. L. Garbers. Inhibition of alkaline phosphatase by substituted xanthines. Biochem. Pharmacol. 28: 1227-1231, 1979.
8. Dalemans, W., P. Barbry, G. Champigny, S. Jallat, K. Dott, D. Dreyer, R. G. Crystal, A. Pavirani, J. P. Lecocq, and M. Lazdunski. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature Lond. 354: 526-528, 1991.
9. Denning, G. M., M. P. Anderson, J. F. Amara, J. Marshall, A. E. Smith, and M. J. Welsh. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature Lond. 358: 761-764, 1992.
10. Dormer, R. L., and M. A. McPherson. Methylxanthines in the Treatment of Cystic Fibrosis. New York: Parthenon, 1994.
11. Drumm, M. L., D. J. Wilkinson, L. S. Smit, R. T. Worrell, T. V. Strong, R. A. Frizzell, D. C. Dawson, and F. S. Collins. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science Wash. DC 254: 1797-1799, 1991.
12. - channels by protein kinase A corrected by insertion of CFTR. Nature Lond. 358: 581-584, 1992.
13. Eidelman, O., C. Guay-Broder, P. J. van Galen, K. A. Jacobson, C. Fox, R. J. Turner, Z. I. Cabantchik, and H. B. Pollard. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Proc. Natl. Acad. Sci. USA 89: 5562-5566, 1992.
14. Farley, J. R., J. L. Ivey, and D. J. Baylink. Human skeletal alkaline phosphatase. Kinetic studies including pH dependence and inhibition by theophylline. J. Biol. Chem. 255: 4680-4686, 1980.
15. Finkbeiner, W. E., S. D. Carrier, and C. E. Teresei. Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands and lung carcinomas. Am. J. Respir. Cell Mol. Biol. 9: 547-556, 1994.
16. Finkbeiner, W. E., J. H. Widdicombe, L. Hu, and C. B. Basbaum. Bovine tracheal serous cell secretion: role of cAMP and cAMP-dependent protein kinase. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L574-L581, 1992.
17. Gabriel, S. E., L. L. Clarke, R. C. Boucher, and M. J. Stutts. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature Lond. 363: 263-268, 1993.
18. Gray, M. A., S. Plant, and B. E. Argent. cAMP-regulated whole cell chloride currents in pancreatic duct cells. Am. J. Physiol. 264 (Cell Physiol. 33): C591-C602, 1993.
19. Gregory, R. J., S. H. Cheng, D. P. Rich, J. Marshall, S. Paul, K. Hehir, L. Ostedgaard, K. W. Klinger, M. J. Welsh, and A. E. Smith. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature Lond. 347: 382-386, 1990.
20. Grubb, B., E. Lazarowski, M. Knowles, and R. Boucher. Isobutylmethylxanthine fails to stimulate chloride secretion in cystic fibrosis airway epithelia. Am. J. Respir. Cell Mol. Biol. 8: 454-460, 1993.
21. - conductance. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L502-L512, 1994.
22. Haws, C. M., I. Nepomuceno, H. Wakelee, T. Law, M. E. Krouse, H. Nguyen, and J. J. Wine. Activation and kinetic of wildtype and ΔF508-CFTR channels in C127 mouse mammary epithelial cells (Abstract). Pediatr. Pulmonol. 10: 73A, 1994.
23. Hyde, S. C., P. Emsley, M. J. Hartshorn, M. M. Mimmack, U. Gileadi, S. R. Pearce, M. P. Gallagher, D. R. Gill, R. E. Hubbard, and C. F. Higgins. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature Lond. 346: 362-365, 1990.
24. Kartner, N., O. Augustinas, T. J. Jensen, A. L. Naismith, and J. R. Riordan. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat. Genet. 1: 321-327, 1992.
25. Kelley, T. J., L. Al-Nakkash, and M. L. Drumm. CFTR-mediated chloride permeability is regulated by type III phosphodiesterase in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 13: 657-664, 1995.
26. Ko, Y. H., P. J. Thomas, M. R. Delannoy, and P. L. Pedersen. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J. Biol. Chem. 268: 24330-24338, 1993.
27. Kondo, M., W. E. Finkbeiner, and J. H. Widdicombe. Simple technique for culture of highly differentiated cells from dog tracheal epithelium. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L106-L117, 1991.
28. Li, C., M. Ramjeesingh, E. Reyes, T. Jensen, X. Chang, J. M. Rommens, and C. E. Bear. The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR. Nat. Genet. 3: 311-316, 1993.
29. Logan, J., D. Hiestand, P. Daram, Z. Huang, D. D. Muccio, J. Hartman, B. Haley, W. J. Cook, and E. J. Sorscher. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J. Clin. Invest. 94: 228-236, 1994.
30. Marshall, J., S. Fang, L. S. Ostedgaard, C. R. O'Riordan, D. Ferrara, J. F. Amara, H. T. Hoppe, R. K. Scheule, M. J. Welsh, A. E. Smith, and S. H. Cheng. Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro. J. Biol. Chem. 269: 2987-2995, 1994.
31. McPherson, M. A., R. L. Dormer, N. A. Bradbury, J. A. Dodge, and M. C. Goodchild. Defective β-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients. Lancet 2: 1007-1008, 1986.
32. Rich, D. P., M. P. Anderson, R. J. Gregory, S. H. Cheng, S. Paul, D. M. Jefferson, J. D. McCann, K. W. Klinger, A. E. Smith, and M. J. Welsh. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature Lond. 347: 358-363, 1990.
33. Schoumacher, R. A., J. Ram, M. C. Iannuzzi, N. A. Bradbury, R. W. Wallace, C. T. Hon, D. R. Kelly, S. M. Schmid, F. B. Gelder, T. A Rado, and R. A. Frizzell. A cystic fibrosis pancreatic adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 87: 4012-4016, 1990.
34. - channels. Am. J. Physiol. 267 (Cell Physiol. 36): C272-C281, 1994.
35. Smit, L. S., D. J. Wilkinson, M. K. Mansoura, F. S. Collins, and D. C. Dawson. Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA 90: 9963-9967, 1993.
36. Smith, P. L., M. J. Welsh, J. S. Stoff, and R. A. Frizzell. Chloride secretion by canine tracheal epithelium. I. Role of intracellular cAMP levels. J. Membr. Biol. 70: 215-226, 1982.
37. Tresize, A. E., and M. Buchwald. In vivo cell-specific regulation of the cystic fibrosis transmembrane conductance regulator. Nature Lond. 353: 434-437, 1991.
38. Venglarik, C. J., R. J. Bridges, and R. A. Frizzell. A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells. Am. J. Physiol. 259 (Cell Physiol. 28): C358-C364, 1990.
39. Ward, C. L., and R. R. Kopito. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269: 25710-25718, 1994.
40. Welsh, M. J., G. M. Denning, L. S. Ostedgaard, and M. P. Anderson. Dysfunction of CFTR bearing the delta F508 mutation. J. Cell. Sci. Suppl. 17: 235-239, 1993.
41. Welsh, M. J., and A. E. Smith. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73: 1251-1254, 1993.
42. Worrell, R. T., A. G. Butt, W. H. Cliff, and R. A. Frizzell. A volume-sensitive chloride conductance in human colonic cell line T84. Am. J. Physiol. 256 (Cell Physiol. 25): C1111-C1119, 1989.
43. Yang, Y., D. C. Devor, J. F. Engelhardt, S. A. Ernst, T. V. Strong, F. S. Collins, J. A. Cohn, R. A. Frizzell, and J. M. Wilson. Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum. Mol. Genet. 2: 1253-1261, 1993.